1.
J Pediatr
; 157(5): 856-7, 2010 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20659741
RESUMO
Propafenone, an antiarrhythmic drug that is effective for treating supraventricular tachycardias, can induce well-known proarrhythmic and systemic adverse effects. We describe a previously unreported adverse effect in 3 newborns: oral propafenone-induced profuse oral secretions and respiratory distress of sufficient severity to necessitate discontinuation of propafenone.